Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Descending
May 13, 2013 stahl neil Officer Sell 23,038 276.71 - 277.12
Dec 31, 2013 powchik peter Officer Automatic Sell 27,332 276.09
May 13, 2013 aberman michael s Officer Automatic Sell 6,971 275.97
Jun 30, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 212,400 275.68 - 284.53
Sep 9, 2013 schleifer leonard s Officer Automatic Sell 5,000 275.04 - 277.12
Feb 5, 2014 sanofi Beneficial Owner (10% or more) Buy 206,978 274.64 - 288.13
Jan 28, 2014 sanofi Beneficial Owner (10% or more) Buy 83,235 273.44 - 279.26
Dec 12, 2013 yancopoulos george Officer Automatic Sell 9,382 273.06
Jan 2, 2014 powchik peter Officer Automatic Sell 20,668 272.88 - 277.50
Dec 16, 2013 goldberg murray a Officer Automatic Sell 5,157 272.73
Dec 16, 2013 powchik peter Officer Automatic Sell 21,617 272.73
Dec 16, 2013 stahl neil Officer Automatic Sell 9,302 272.73
Dec 16, 2013 yancopoulos george Officer Automatic Sell 42,974 272.73
Jun 27, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 50,000 272.70 - 277.43
Dec 20, 2013 powchik peter Officer Automatic Sell 133 271.09
Dec 17, 2013 powchik peter Officer Automatic Sell 8 270.00
May 10, 2013 sing george l Director Sell 5,000 270.00
Jan 27, 2014 sanofi Beneficial Owner (10% or more) Buy 74,685 269.77 - 275.31
May 17, 2013 brown michael s Director Sell 5,000 269.00 - 270.20
May 10, 2013 stahl neil Officer Disposition (Non Open Market) 32,400 268.40
Showing 121-140 of 863 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)